Cargando…
Biomarkers: Our Path Towards a Cure for Alzheimer Disease
Over the last decade, biomarkers have significantly improved our understanding of the pathophysiology of Alzheimer disease (AD) and provided valuable tools to examine different disease mechanisms and their progression over time. While several markers of amyloid, tau, neuronal, synaptic, and axonal i...
Autor principal: | Tarawneh, Rawan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705771/ https://www.ncbi.nlm.nih.gov/pubmed/33293784 http://dx.doi.org/10.1177/1177271920976367 |
Ejemplares similares
-
Clusterin as a Potential Biomarker of Obesity-Related Alzheimer’s Disease Risk
por: Bradley, David
Publicado: (2020) -
Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers
por: Farotti, Lucia, et al.
Publicado: (2020) -
Fluid Biomarkers for Synaptic Dysfunction and Loss
por: Camporesi, Elena, et al.
Publicado: (2020) -
‘It’s the progression, doctor’: what patients with motor neurone disease really are interested in
por: Grosskreutz, Julian
Publicado: (2017) -
Temporospatial components of brain ERPs as biomarkers for Alzheimer's disease
por: Chapman, Robert M., et al.
Publicado: (2018)